H.R. 6161 — Introduced in House

I 118th CONGRESS 1st Session H. R. 6161 IN THE HOUSE OF REPRESENTATIVES November 1, 2023Mr. Molinaro (for himself, Ms. Pettersen, Mr. LaHood, Mr. Carey, Mr. Trone, and Mr. Pappas) introduced the following bill; which was referred to the Committee on Ways and Means A BILL To amend the Internal Revenue Code of 1986 to allow amounts paid for over-the-counter naloxone to be taken into account in determining the deduction for medical expenses. 1. Short title This Act may be cited as the Supporting Access to Vital and Affordable Care for Everyone Act of 2023 or as the SAVE Act of 2023. 2. Amounts paid for over-the-counter naloxone taken into account in determining the deduction for medical expenses (a) In general Section 213(b) of the Internal Revenue Code of 1986 is amended by inserting or naloxone after insulin. (b) Effective date The amendment made by this section shall apply to taxable years ending after the date of the enactment of this Act.